Position in REGN
as of Jun 30, 2026
· filed Aug 13, 2026
Position Value
$518,762,829
-$654,253,036 QoQ
Shares Held
831,964
-45.2% QoQ
Ownership
0.808%
of shares outstanding
% of Portfolio
0.02%
of 13F equity value
Holder Rank
#22
of 1,322 holders
Holding Since
Mar 2020
26 quarters on record
Voting authority
Sole 57%
Shared 0%
None 43%
Common Shares in REGN Over Time
Shares Held
Position Value (USD)
Position in Biotechnology
Healthcare · as of Jun 30, 2026FMR LLC holds $61,424,667,385 across 370 Biotechnology names. REGN ranks #31 (0.8% of the industry book) .
| # | Ticker | Company | Shares | Value (USD) | Open |
|---|---|---|---|---|---|
| 1 | ARGX |
Argenx SE
|
5,231,452 | $4,853,584,218 | |
| 2 | ALNY |
Alnylam Pharmaceuticals, Inc.
|
15,023,962 | $4,522,663,276 | |
| 3 | MRNA |
Moderna, Inc.
|
51,859,891 | $3,631,748,165 | |
| 4 | ROIV |
Roivant Sciences Ltd.
|
81,020,390 | $2,867,311,601 | |
| 5 | RVMD |
Revolution Medicines, Inc.
|
12,200,422 | $2,284,895,029 | |
| 6 | IONS |
Ionis Pharmaceuticals Inc
|
24,631,956 | $1,953,067,789 | |
| 7 | INSM |
INSMED Inc
|
16,143,583 | $1,721,228,815 | |
| 8 | KRYS |
Krystal Biotech, Inc.
|
4,418,197 | $1,642,111,277 |
All Filings in REGN
Export CSV
26 filing rows on record
| Report Date | Value (USD) | Shares | Type | Discretion | Filed | |
|---|---|---|---|---|---|---|
| 2026-06-30 | $518,762,829 | 831,964 | Shares | Defined | 2026-08-13 | |
| 2026-03-31 | $1,173,015,865 | 1,518,192 | Shares | Defined | 2026-05-15 | |
| 2025-12-31 | $1,790,403,407 | 2,319,566 | Shares | Defined | 2026-02-17 | |
| 2025-09-30 | $1,088,461,943 | 1,935,835 | Shares | Defined | 2025-11-13 | |
| 2025-06-30 | $1,746,701,775 | 3,327,051 | Shares | Defined | 2025-08-14 | |
| 2025-03-31 | $4,819,249,927 | 7,598,584 | Shares | Defined | 2025-05-12 | |
| 2024-12-31 | $5,840,806,104 | 8,199,579 | Shares | Defined | 2025-02-13 | |
| 2024-09-30 | $10,893,685,796 | 10,362,701 | Shares | Defined | 2024-11-13 | |
| 2024-06-30 | $11,192,916,655 | 10,649,474 | Shares | Defined | 2024-08-13 | |
| 2024-03-31 | $10,389,186,355 | 10,794,072 | Shares | Defined | 2024-05-13 | |
| 2023-12-31 | $9,061,682,417 | 10,317,415 | Shares | Defined | 2024-02-13 | |
| 2023-09-30 | $8,098,660,477 | 9,840,892 | Shares | Defined | 2023-11-13 | |
| 2023-06-30 | $6,589,999,790 | 9,171,375 | Shares | Defined | 2023-08-11 | |
| 2023-03-31 | $7,756,643,677 | 9,440,096 | Shares | Defined | 2023-08-11 | |
| 2022-12-31 | $8,006,368,034 | 11,096,991 | Shares | Defined | 2023-02-13 | |
| 2022-09-30 | $7,446,509,723 | 10,809,746 | Shares | Defined | 2022-11-10 | |
| 2022-06-30 | $6,015,456,513 | 10,176,199 | Shares | Defined | 2022-08-12 | |
| 2022-03-31 | $6,972,343,619 | 9,983,024 | Shares | Defined | 2022-05-13 | |
| 2021-12-31 | $6,354,964,917 | 10,062,967 | Shares | Defined | 2022-02-14 | |
| 2021-09-30 | $6,698,102,585 | 11,067,951 | Shares | Defined | 2022-02-14 | |
| 2021-06-30 | $6,094,059,025 | 10,910,694 | Shares | Defined | 2021-08-13 | |
| 2021-03-31 | $5,174,253,833 | 10,935,989 | Shares | Defined | 2021-05-14 | |
| 2020-12-31 | $5,546,863,214 | 11,481,574 | Shares | Defined | 2021-02-08 | |
| 2020-09-30 | $7,119,454,451 | 12,718,308 | Shares | Defined | 2020-11-13 | |
| 2020-06-30 | $7,772,849,300 | 12,463,480 | Shares | Defined | 2020-08-24 | |
| 2020-03-31 | $4,133,037,928 | 8,464,310 | Shares | Defined | 2020-05-14 | |
| No filing history on record for this holder in this stock. | ||||||